Refresh

AstraZeneca Pharma India Ltd. - Research Center

506820 ASTRAZEN Group (A) BSE data
Back to Company

Results

Statement

More

Half Yearly results in brief
(Rs crore)
Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21 Sep ' 20

Sales

606.54 468.46 432.49 373.11 403.05

Operating profit

120.00 68.69 52.63 33.55 64.33

Interest

0.65 0.35 0.44 0.51 0.55

Gross profit

135.83 79.25 61.21 38.78 71.14

EPS (Rs)

42.49 21.09 15.76 8.88 17.99
Half yearly  results in details
Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21 Sep ' 20

Other income

16.48 10.91 9.01 5.74 7.36

Stock adjustment

-67.96 -12.28 15.53 -1.06 -11.12

Raw material

57.88 35.65 49.30 40.31 44.83

Power and fuel

- - - - -

Employee expenses

120.24 129.56 117.73 112.48 111.99

Excise

- - - - -

Admin and selling expenses

- - -20.12 20.12 20.73

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

376.37 246.83 217.43 167.71 172.30

Provisions made

- - - - -

Depreciation

7.47 7.88 7.91 9.04 9.18

Taxation

38.55 18.65 13.89 7.55 16.98

Net profit / loss

106.23 52.72 39.40 22.19 44.97

Extra ordinary item

16.43 - - - -

Prior year adjustments

- - - - -

Equity capital

5.00 5.00 5.00 5.00 5.00

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

- - - - -

Agg.of non promotoholding (%)

- - - - -

OPM (%)

19.79 14.66 12.17 8.99 15.96

GPM (%)

21.80 16.53 13.86 10.24 17.33

NPM (%)

17.05 11.00 8.92 5.86 10.96
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com